Clinical Trial Update: Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating induction, consolidation, and maintenance therapy with isatuximab, carfilzomib, lenalidomide, and dexamethasone for multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Kyprolis (carfilzomib)
• Revlimid (lenalidomide)
• SARCLISA (isatuximab)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING